RK
Rene Kristian Lindell
About Rene Kristian Lindell
Data last updated:
Rene Kristian Lindell is a Director at Finorion Pharma India Private Limited (since 2024). The company operates in Pharma. Finorion Pharma India Private Limited reported revenue of ₹38.28 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Finorion Pharma India Private Limited U74120MH2011PTC225361 | Director | 05 Aug 2024 | 2011 | ₹38.28 Cr (FY 2025) | Active |
Board colleagues of Rene Kristian Lindell
| Name | DIN | Company | Designation |
|---|---|---|---|
| Johanna Linnea Pakkanen | 07320123 | Finorion Pharma India Private Limited | Director |
| Mikko Tapani Kemppainen | 11046428 | Finorion Pharma India Private Limited | Director |
| Olli Heikki Huotari | 05119036 | Finorion Pharma India Private Limited | Director |
| Pekka Juhani Kankaanpaa | 11048805 | Finorion Pharma India Private Limited | Director |
| Samrudhi Mangesh Utturkar | 08162610 | Finorion Pharma India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rene Kristian Lindell
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rene Kristian Lindell
Rene Kristian Lindell currently holds 1 directorship: Finorion Pharma India Private Limited (Director, since 05 Aug 2024, revenue ₹38.28 Cr (FY 2025)).
Rene Kristian Lindell was first appointed on 05 Aug 2024 as Director at Finorion Pharma India Private Limited.
The current boards of Rene Kristian Lindell's companies include Johanna Linnea Pakkanen (Finorion Pharma India Private Limited), Mikko Tapani Kemppainen (Finorion Pharma India Private Limited), Olli Heikki Huotari (Finorion Pharma India Private Limited), Pekka Juhani Kankaanpaa (Finorion Pharma India Private Limited), Samrudhi Mangesh Utturkar (Finorion Pharma India Private Limited).